Literature DB >> 12358520

Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors.

Natalie A Dales1, Alexandra E Gould, James A Brown, Emily F Calderwood, Bing Guan, Charles A Minor, James M Gavin, Paul Hales, Virendar K Kaushik, Michael Stewart, Peter J Tummino, Chad S Vickers, Timothy D Ocain, Michael A Patane.   

Abstract

Angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a recently identified zinc metalloprotease with carboxypeptidase activity that was identified using our genomics platform. We implemented a rational design approach to identify potent and selective ACE2 inhibitors. To this end, picomolar inhibitors of ACE2 were designed and synthesized.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358520     DOI: 10.1021/ja0277226

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  66 in total

1.  Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.

Authors:  Minghao Ye; Jan Wysocki; Francisco R Gonzalez-Pacheco; Mahmoud Salem; Karla Evora; Laura Garcia-Halpin; Marko Poglitsch; Manfred Schuster; Daniel Batlle
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

2.  Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney.

Authors:  Nadja Grobe; Khalid M Elased; David R Cool; Mariana Morris
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

3.  Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays.

Authors:  Kim Brint Pedersen; Srinivas Sriramula; Kavaljit H Chhabra; Huijing Xia; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-31       Impact factor: 3.619

Review 4.  Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.

Authors:  Vaibhav B Patel; Jiu-Chang Zhong; Maria B Grant; Gavin Y Oudit
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

Review 5.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

6.  Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice.

Authors:  John J Byrnes; Stefan Gross; Courtney Ellard; Kelly Connolly; Stephen Donahue; Dominic Picarella
Journal:  Inflamm Res       Date:  2009-06-11       Impact factor: 4.575

7.  Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.

Authors:  Paul J Garabelli; J Gregory Modrall; Josef M Penninger; Carlos M Ferrario; Mark C Chappell
Journal:  Exp Physiol       Date:  2008-03-20       Impact factor: 2.969

8.  MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides.

Authors:  Patricia E Gallagher; Carlos M Ferrario; E Ann Tallant
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-03       Impact factor: 4.249

9.  Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.

Authors:  Vinayak Shenoy; Altin Gjymishka; Yagna P Jarajapu; Yanfei Qi; Aqeela Afzal; Katya Rigatto; Anderson J Ferreira; Rodrigo A Fraga-Silva; Patrick Kearns; Jane Yellowlees Douglas; Deepmala Agarwal; Kamal K Mubarak; Chastity Bradford; William R Kennedy; Joo Y Jun; Anandharajan Rathinasabapathy; Erin Bruce; Dipankar Gupta; Arturo J Cardounel; J Mocco; Jawaharlal M Patel; Joseph Francis; Maria B Grant; Michael J Katovich; Mohan K Raizada
Journal:  Am J Respir Crit Care Med       Date:  2013-01-31       Impact factor: 21.405

Review 10.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.